Terminated NA INTERVENTIONAL 2-arm NCT02524249

Early Versus Late Caffeine for ELBW Newborns

A Randomized Double Blind Controlled Trial of Early Versus Late Caffeine for Extremely Low Birth Weight Newborns

Sponsor: The Gerber Foundation

Conditions Apnea of Prematurity Bronchopulmonary Dysplasia

Interventions Caffeine Placebo (dextrose)

Updated 8 times since 2017 Last updated: Apr 25, 2022 Started: Sep 30, 2015 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Frequent protocol violations

Other Apnea of Prematurity trials with similar outcome

Browse all Apnea of Prematurity trials

A NA clinical study on Apnea of Prematurity and Bronchopulmonary Dysplasia, this trial is terminated or withdrawn. The trial is conducted by The Gerber Foundation and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jun 2022 — Jul 2024 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jan 2021 — Jun 2022 [monthly]

Unknown Status NA
Jan 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jan 2019 [monthly]

Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Gerber Foundation
Wayne State University

Data source: Wayne State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Detroit, United States